2025 Prescription Side effects 
World of DTC Marketing
JULY 17, 2022
Novo Nordisk more than doubled its sales targets for obesity drugs to $3.7bn by 2025. It has to persuade patients to sign up for some heinous side effects. Payers also face hurdles, so patients must obtain permission before filling a prescription. Its share price has risen 26 percent in the past year.
European Pharmaceutical Review
OCTOBER 17, 2024
Additionally, EURneffy could alleviate the risk of accidental needle-related side effects (such as injection into the blood vessel and hand) 3 and it has the attributes of being smaller in size, has better temperature sensitivity, and is less complex to use compared to needle-based injectors.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
NOVEMBER 1, 2022
Given the national-level focus on developing HER-based solutions, companies are developing AI and machine learning tools to improve the accuracy and efficiency of prescription services for several diseases. Israeli company Taliaz’s tool, named Predictix, uses AI and EHR data to improve mental health prescription services.
PM360
AUGUST 9, 2022
billion in 2025. The combined solution enables health plans and self-insured employers to realize immediate pharmacy cost savings and near-term medical cost reductions by integrating Levrx’s plan-specific and real-time prescription insights into the Adhere Platform medication optimization offerings. from 2021 and reach $4.2
Pharmaceutical Technology
JUNE 1, 2023
For context, in January 2023, the FDA accepted Intercept’s resubmission of its NDA for OCA as a Class 2 resubmission (which has a six-month review period in NASH) and set a Prescription Drug User Fee Act (PDUFA) date of 22 June 2023. risk reduction compared with placebo).
Expert insights. Personalized for you.
209 
Let's personalize your content